ClinVar Miner

Submissions for variant NM_000051.4(ATM):c.4611+9C>G

gnomAD frequency: 0.00001  dbSNP: rs760704159
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000443681 SCV000512162 likely benign not specified 2017-11-27 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001089223 SCV000558425 likely benign Ataxia-telangiectasia syndrome 2024-02-01 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000590322 SCV000694286 uncertain significance not provided 2015-10-22 criteria provided, single submitter clinical testing Variant summary: ATM c.4611+9C>G affects a non-conserved nucleotide, Mutation Taster predicts the change is a polymorphism, and 4/5 Alamut algorithms predict no significant change to splicing. This variant was found in 2/121332 control chromosomes at a frequency of 0.0000165, which does not significantly exceed maximal expected frequency of a pathogenic ATM allele (0.0039528). The variant of interest has not been reported in affected individuals via publications and/or reputable databases/clinical laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant was classified as a variant of uncertain significance (VUS) until additional information becomes available.
Color Diagnostics, LLC DBA Color Health RCV000773191 SCV000906763 likely benign Hereditary cancer-predisposing syndrome 2016-08-15 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV004591152 SCV005085062 likely benign Familial cancer of breast 2024-05-20 criteria provided, single submitter clinical testing This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.